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Edited by Horst FeldmannAbstract The Lon protease from the archaeon Thermoplasma
acidophilum (TaLon) is composed of an N-terminal ATPase
associated with various cellular activities (AAAþ) domain and a
C-terminal Lon protease domain. Although related in sequence
to the soluble Lon proteases, TaLon was shown to be membrane-
bound in its native host and also when expressed in Escherichia
coli. Recombinant TaLon was puriﬁed as a functional high-
molecular weight complex displaying ATPase and proteolytic
activity. Mutagenesis of conserved AAAþ residues revealed that
the Walker A and B motifs, and the sensor 1 and sensor 20
residues were essential for the ATPase activity, while the sensor
2 and the arginine ﬁnger were involved in activation of the
protease domain.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Archaea; Lon protease1. Introduction
Lon is a one-component ATP-dependent protease, where the
ATP-hydrolysing ATPase associated with various cellular ac-
tivities (AAAþ) domain and the proteolytic domain are fused
consecutively in a single polypeptide chain [1]. Lon is univer-
sally distributed and found in bacteria, eukaryotic organelles
and archaea [2–6]. The best-studied representative is Esche-
richia coli Lon (EcLon), also called La, a non-essential heat-
shock protein that degrades abnormal and short lived regula-
tory proteins [7,8]. Lon proteases from many other bacteria
have been studied and conﬁrmed the importance of Lon in
regulated protein degradation [9].* Corresponding author. Fax: +49-89-8578-2641.
E-mail address: zwickl@biochem.mpg.de (P. Zwickl).
Abbreviations: AAAþ, ATPase associated with various cellular activ-
ities; AMC, 7-amido-4-methylcoumarin; AMPPNP, adenosine 50-(b,c-
imino)-triphosphate; DDM, dodecyl-b-D-maltopyranoside; EcFtsH,
Escherichia coli FtsH; EcLon, Escherichia coli Lon; FITC, ﬂuorescein
isothiocyanate; IPTG, isopropyl-1-thio-b-D-galactopyranoside; MNA,
4-methoxy-2-naphthylamide; Suc, succinyl; TaLon, Thermoplasma
acidophilum Lon; TaPIP, Thermoplasma acidophilum proline imino-
peptidase; TkLon Thermococcus kodakarensis Lon; wt, wild-type
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doi:10.1016/j.febslet.2004.08.021Surprisingly, sequence analysis predicted two transmem-
brane regions for the Thermoplasma Lon homologue (TaLon)
[10], while all bacterial and eukaryotic Lon polypeptides are
devoid of transmembrane regions and are isolated as soluble
proteases [7]. More recently, the Lon protease from Thermo-
coccus kodakarensis (TkLon) was shown to be located in the
membrane, but was puriﬁed from the soluble fraction when
expressed in E. coli [11]. In contrast to bacteria, which have a
multitude of energy-dependent proteases, archaea contain only
two ATP-dependent proteases, namely the soluble protea-
some–PAN system and the Lon protease [12,13]. Thus, ar-
chaea lack a membrane-bound protease, like the FtsH protease
of the bacterial cytoplasm membrane and the m- and i-AAA
proteases of the mitochondrial inner membrane [14–17].
Therefore, it is tempting to speculate that the archaeal Lon
protease is a functional homologue of the bacterial and mi-
tochondrial membrane-bound proteases and is responsible for
the degradation of membrane proteins.
In this study, we showed that the TaLon protease is mem-
brane-associated in Thermoplasma cells and when expressed in
E. coli. The recombinant TaLon protease was puriﬁed from
the membrane-fraction as a deﬁned complex with ATPase
activity. The proteolytic activity was processive, as described
for related ATP-dependent enzymes [3]. A systematic muta-
tional analysis of conserved AAAþ residues yielded TaLon
mutants impaired to diﬀerent extents in ATPase and protease
activity. Comparative analysis of wt and mutant TaLon
revealed insights into the individual role of conserved
AAAþ residues in the intramolecular regulation of this ATP-
dependent protease.2. Materials and methods
2.1. Fractionation of Thermoplasma acidophilum cells
Prof. Dr. Karl O. Stetter (University of Regensburg, Germany)
kindly provided Thermoplasma cells. Whole cell extracts were gener-
ated by thawing frozen Thermoplasma cells in Tris-buﬀer (50 mM Tris,
pH 7.5, 5 mM MgCl2, and 1 mM ATP) on ice. Under stirring, the pH
of the cell suspension was adjusted to 7.0 with 1 M Tris, pH 11. After
the addition of DNaseI, the cells were disrupted by two cycles at 15 000
psi using an EmulsiFlex-C5 (Avestin) cell disrupter. The suspension
was centrifuged (15 min, 12 000·g, 4 C) and the supernatant (whole
cell extract (H)) was applied to an additional 200 000·g centrifugation
step (2 h, 4 C) separating cytosol from the membrane pellet.blished by Elsevier B.V. All rights reserved.
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The full-length lonta was ampliﬁed from genomic DNA using the
following primers: 50-ggaattccatatggaagaaaacattgagagcgtcgagg-30
(sense, NdeI site underlined) and 50-ccgctcgagagctgcattatttcctg-
ctcttgtgg-30 (antisense, BamHI site underlined). The PCR product was
digested with NdeI and XhoI and ligated with pET22b(+) (Ligation
Kit, TakaraShuzo). The resulting plasmid (pET22b(+)-TaLon-His6)
encoded for full-length TaLon and two additional residues (leucine
and glutamate) before the C-terminal His6-tag. Eurogentec generated
the anti-Lon peptide antibody. Anti-His6 antibody was purchased
from Santa Cruz Biotechnology.
2.3. Generation of active site mutants
Site-directed mutagenesis was performed using the QuickChange
Kit (Stratagene). pET22b(+)-TaLon-His6 served as PCR template for
the mutant proteins K63A, D241A, N293A, R305A, R375A, and
R382A. The respective primers are listed with the mutated codons
underlined: K63A 50-ggagagccgggtactggagcctcgatgcttgcacagtcaatgg-30
(sense), 50-ccattgactgtgcaagcatc-gaggctccagtaccggctctcc-30 (antisense);
D241A 50-gggtgtcctattcatagccgagataaaccttctcaggcccg-30 (sense), 50-cgg-
gcctgagaaggtttatctcggctatgaataggacaccc-30 (antisense); N293A 50-ctcg-
ttgctgccggagcctatgatgcgata-agaaatatgc-30 (sense), 50-gcatatttcttatcgcat-
cataggctccggcagcaacgag-30 (antisense); R305A 50-gcaccctgcg-ctcgcgt-
caaggatacgcgg-30 (sense), 50-ccgcgtatccttgacgcgagcgcagggtgc-30 (anti-
sense); R375A 50-gctgacct-tgaggctcgcggagctgggcggactcg-30 (sense);
50-cgagtccgcccagctccgcgagcctcaaggtcagc-30 (antisense); R382A 50-gctg-
ggcggactcgtcgcggtagccggagatatagc-30 (sense), 50-gctatatctccggctaccgcg-
acgagtccgcccagc-30 (antisense). All plasmids were checked by DNA
sequencing of the full-length gene (MWG).2.4. Expression and puriﬁcation of TaLon
Cells of E. coli BL21(DE3)C43 (Avidis) harbouring pET22b(+)-
TaLonHis6(-wt, -K63A, -D241A, -N293A, -R305A, -R375A or
-R382A) were grown at 37 C in LB medium containing 100 lg
ampicillin/ml. At an optical density of 0.6 (OD 600 nm), isopropyl-1-
thio-b-D-galactopyranoside (IPTG) was added to a ﬁnal concentration
of 1 mM. After 4 h the cells were harvested (4000·g, 10 min, 4 C),
washed with 50 mM Tris, pH 7.5, and stored until puriﬁcation at )80
C. For puriﬁcation of Ta LonHis6 (72 kDa), about 20 g of cells were
thawed in buﬀer A (50 mM Na2HPO4, pH 8.0, 300 mM NaCl, 20 mM
MgCl2, and 10 mM imidazole) and disrupted in four cycles at 15 000
psi using an EmulsiFlex-C5 (Avestin) cell disrupter. The suspension
was centrifuged (15 min, 12 000·g, 4 C) and the supernatant was
applied to a 200 000·g centrifugation step (2 h, 4 C). The pellet
containing the membrane fraction was diluted to a total volume of 100
ml in solubilisation buﬀer (50 mM Na2HPO4, pH 8.0, 300 mM NaCl,
20 mM MgCl2, 10 mM imidazole, and 1.5% (w/v) dodecyl-b-D-
maltopyranoside, Anatrace (DDM)). Solubilisation of the membranes
was carried out for 2 h at 4 C under gentle stirring and followed by
centrifugation (1 h, 100 000·g, 4 C). The remaining supernatant was
applied to a 25 ml Ni2þ–NTA (Qiagen) column (0.5 ml/min, 4 C). The
column was washed with 10 column volumes (CVs) of buﬀer B (50 mM
Na2HPO4, pH 8.0, 300 mM NaCl, 20 mM MgCl2, 20 mM imidazole,
and 1 mM DDM) and eluted with a linear gradient of imidazole (20–
250 mM) in buﬀer B (10 CVs). The fractions containing TaLon were
pooled, concentrated (Jumbosep 100K, PallFiltron), and applied to a
Superdex 200 gel ﬁltration column (HiLoad 26/60, Amersham Bio-
sciences) equilibrated in buﬀer C (50 mMMES, pH 6.2, 300 mMNaCl,
20 mM MgCl2, and 1 mM DDM). After separation (2 ml/min), the
fractions containing TaLonHis6 were pooled, concentrated and stored
at )80 C.2.5. Peptide hydrolysis
Peptidase activity of TaLon was assayed by hydrolysis of the ﬂu-
orogenic peptide Suc-LLVY-AMC (succinyl-LLVY-7-amido-4-meth-
ylcoumarin, Bachem). The release of the ﬂuorophore AMC was
recorded over time (excitation at 320 nm, emission at 460 nm) with a
ﬂuorescence spectrophotometer (Fluostar Optima, BMG Labtechnol-
ogies). The assay was performed in a total volume of 200 ll in a 96-well
plate. 4 lg TaLon (46.3 nM; assuming a hexameric complex) and 12.8
lg PIP (1.83 lM) [18] were incubated with 100 lM Suc-LLVY-AMC
in assay buﬀer (50 mM MES, pH 6.2, 20 mM MgCl2, and 0.5 mM
DDM) with or without 2 mM of nucleotide (ATP, ADP, ATPcS or
adenosine 50-(b; c-imino)-triphosphate (AMPPNP)) at 60 C [18]. Thedegradation of Suc-LLVY-AMC by PIP alone was substracted and the
initial slope of the curve was calculated.
2.6. Degradation of FITC casein
5 lg (58 nM, assuming a hexameric complex) TaLon was incubated
with 25 lg (5 lM) ﬂuorescein isothiocyanate (FITC) casein in 200 ll
assay buﬀer with or without 2 mM nucleotide (ATP, ADP, ATPcS or
AMPPNP). Degradation of FITC casein was monitored continuously
(excitation at 480 nm, emission at 520 nm) in a ﬂuorescence spectro-
photometer (Fluostar Optima, BMG Labtechnologies) at 60 C. The
blank curve of FITC casein incubated in assay buﬀer was taken as a
baseline and the initial slopes of reaction curves were calculated.
2.7. ATPase activity
ATPase activity was measured by determining the amount of inor-
ganic phosphate formed upon ATP hydrolysis as a complex with
malachite green and ammonium molybdate [19]. 25 ll of assay buﬀer
containing 0.75 lg TaLon was preincubated for 10 min at 60 C with
or without 5 lM of FITC casein. The reaction was started by addition
of 25 ll standard buﬀer containing 4 mM ATP. After further incu-
bation for 20 min at 60 C, the reaction was stopped by addition of 800
ll malachite green solution followed by 100 ll citrate solution (34% (w/
v)). After 30 min incubation at RT, absorption at 640 nm was deter-
mined in a Perkin–Elmer UV/VIS spectrometer Lambda 40. The
amount of phosphate in the sample was calculated from a standard
curve of 0–15 nmol KH2PO4.
2.8. Reversed-phase HPLC analysis of degradation products
1.25 mg/ml b-casein (Sigma) was incubated with 20 lg/ml TaLon
protease (46.5 nM; assuming a hexameric complex) in 600 ll of 25 mM
MES, pH 6.2, with 10 mM MgCl2, 1 mM DDM and 2 mM nucleotide
at 60 C. At diﬀerent time points, aliquots of 40 ll were removed from
the mixtures and 0.5 % TFA was added to stop the reaction before
storage at )20 C. 100 ll of each reaction mixture were analysed by
reversed-phase HPLC. The column was equilibrated with 0.1% TFA in
water and eluted with a linear gradient of 0–80% acetonitrile con-
taining 0.08% TFA in 40 min at a ﬂow rate of 0.3 ml/min and the
gradient started 8.8 min after sample injection. Degradation products
were detected by UV at 215 nm.3. Results
3.1. TaLon is membrane-bound
During the sequencing of the T. acidophilum genome an
open reading frame (ORF 1081) was identiﬁed, which showed
signiﬁcant sequence similarity to Lon proteases [10]. The T.
acidophilum Lon (TaLon) protease encompasses an N-terminal
AAAþ domain and a C-terminal protease domain, but lacks
the N-terminal a-helical domain inherent in most bacterial and
eukaryotic Lon homologues. However, the AAAþ domain of
TaLon contains an insert between the Walker A and Walker B
ATPase signatures [20] (Fig. 1), which is not present in any
bacterial or eukaryotic Lon sequence. This insert is found in all
archaeal Lon homologues and is predicted to contain two
consecutive transmembrane helices, suggesting that archaeal
Lon proteases are membrane associated [10].
To test for expression and subcellular localisation of the
TaLon in T. acidophilum cells, an antibody was developed
against the N- and C-terminal peptides of the TaLon protein.
Cytosol and membrane of Thermoplasma cells were separated
by ultra-centrifugation and analysed by Western blotting
(Fig. 2A). The Lon protease was highly enriched in the
membrane fraction, which veriﬁes the predicted membrane
insertion. Membrane localisation was also shown for the Lon
homologue from the extreme thermophilic archaeon Thermo-
coccus kodakarensis (TkLon) [11]. Taken together, this sug-
gests that the predicted transmembrane region of archaeal Lon
Fig. 1. Schematic representation of TaLon. TaLon is comprised of an
N-terminal AAAþ ATPase and a C-terminal Lon protease domain.
The AAAþ domain contains two transmembrane helices (TM1, TM2)
inserted between the Walker A and B motifs. The positions of Sensor
1, Sensor 20, Sensor 2 and the arginine ﬁnger (R-ﬁnger) are indicated
with the respective amino acids.
Fig. 2. Membrane localisation of native and recombinant TaLon
protease. (A) T. acidophilum whole cell extract (H) was split by ultra-
centrifugation into cytosol (C) and membrane (M) fraction. The Ta-
Lon protease was detected by immunoblot analysis with anti-Lon
antibodies (a-Lon). (B) Recombinant expression of TaLonHis6 in E.
coli. Samples from cell culture were taken before ()I) and after in-
duction (+I) with 1 mM IPTG. The whole cell extract (H) was frac-
tionated into cytosol (C) and membrane (M). To conﬁrm the integral
membrane character of TaLonHis6, an aliquot of the membrane
fraction was washed with 0.1 M Na2CO3, pH 11.5 (MW). The crude
membranes were solubilised and TaLonHis6 was isolated by Ni
2þ–
NTA aﬃnity chromatography. The top panel shows Coomassie-
stained SDS-PAGE, the middle and lower panels represent the
immunoblot analysis with anti-His6 (a-His6) and anti-Lon (a-Lon)
antibodies, respectively.
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of the bacterial membrane-bound ATP-dependent protease
FtsH have not been detected in the genome of any archaeon
[12,13]. Thus, the archaeal membrane-bound Lon protease
might represent a functional homologue of the bacterial FtsH
protease and degrade archaeal membrane proteins.3.2. Expression and puriﬁcation of recombinant TaLon
The T. acidophilum lon gene was ampliﬁed from genomic
DNA by PCR and cloned into the bacterial expression vector
pET22b. Overexpression in E. coli led to membrane insertion
of the TaLon protease (Fig. 2B), which indicated that theTaLon membrane anchor was functional in E. coli. The inte-
gral character of TaLon was conﬁrmed by washing the isolated
membranes with 0.1 M Na2CO3 (pH 11.5) (Fig. 2B). The
isolated membranes were solubilised with detergent and re-
combinant TaLon was puriﬁed by Ni2þ–NTA aﬃnity chro-
matography. Subsequent size exclusion chromatography
revealed an apparent molecular weight of 430 kDa, which
suggests that TaLon (72 kDa) assembles into a hexameric
complex. Recently, the soluble protease domain from EcLon
[21] and the AAA-domain of FtsH [22] were crystallised as
hexameric complexes, supporting the hexameric model for
TaLon. Preliminary electron microscopic analysis of TaLon
revealed ring-shaped particles of unknown symmetry (data not
shown).3.3. Peptidase activity
In order to ﬁnd the optimal conditions for the ensuing en-
zymatic characterisation, the ATPase activity of the re-
combinant enzyme was assayed at diﬀerent temperatures, pH
values and Mg2þ concentrations. Highest activity for TaLon
was found at 75 C, pH 5.75, and 10 mM MgCl2. All sub-
sequent assays, if not indicated diﬀerently, were done using
these conditions except for the temperature, which was low-
ered to 60 C in order to match the optimal growth tempera-
ture of T. acidophilum [23] and to reduce thermal autolysis of
ATP.
To measure the peptidase activity of TaLon, a set of 18 di-
verse ﬂuorogenic peptide substrates was tested. An increase in
ﬂuorescence was detected only for Suc-LLVY-AMC, and only
after adding the T. acidophilum proline iminopeptidase (Ta-
PIP) to the reaction mixture. TaPIP is a broad-spectrum
aminopeptidase, which was shown to cleave preferentially after
small and hydrophobic residues but does not cleave Suc-
LLVY-AMC, due to the protecting N-terminal succinyl group
[18]. In the absence of TaPIP, the TaLon protease cleaved the
Suc-LLVY-AMC peptide at the L–L and the L–V bonds as
revealed by mass spectrometry, but did not release the ﬂu-
orophore AMC (data not shown). In the presence of TaPIP the
products of the TaLon cleavages, LVY-AMC and VY-AMC,
were further degraded and AMC was released as measured by
increase in ﬂuorescence.
The peptidase activity of TaLon is modulated by the ATP-
state of its AAAþ domain. In the absence of nucleotide, Ta-
Lon shows a basal activity that is slightly reduced in the
presence of ATP or the non-hydrolysable analogues AMPPNP
and ATPcS, whereas ADP exerts an inhibitory eﬀect on the
peptidase activity (Table 1). Modulation of the peptidase ac-
tivity by nucleotides was described for EcLon, which is highly
stimulated in the presence of ATP (10–30 fold) and strictly
inhibited in the presence of ADP [7]. The inhibition of pepti-
dase activity with increasing ATP concentrations described for
TkLon [11] was neither observed for TaLon (data not shown)
nor for EcLon [7].3.4. Degradation of FITC casein
Protein degradation was monitored with FITC-labelled ca-
sein, a loosely folded protein [24] that is commonly used as a
substrate for ATP-dependent proteases [7]. The ﬂuorescence of
the covalently linked FITC molecules is quenched, and only
upon casein degradation and release of small peptide frag-
ments carrying a FITC label the ﬂuorescence increases [25,26].
Table 1
Relative ATPase and peptidase activities of wt and mutant TaLona
ATPase (%) Peptidase (%)
No nucl. ADP AMPPNP ATPcS ATP
Wt 100 4 100 6 41 3 93 8 73 4 89 2
Mutant Motif
K63A Walker A 0 113 6 130 5 138 13 95 13 103 15
D241A Walker B 5 1 99 5 58 6 66 5 58 5 57 7
N293A Sensor 1 9 1 122 5 77 6 103 10 66 12 78 13
R305A R-ﬁnger 38 2 2 1 3 1 32 11 81 9 81 7
R375A Sensor 20 2 1 112 5 56 4 96 5 74 7 86 8
R382A Sensor 2 24 3 6 1 3 1 28 7 88 6 86 7
aATPase and peptidase activities are given relative to the respective activities of the wt TaLon protease.
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nucleotide, stimulated tenfold in the presence of ATP, and
completely inhibited by ADP (Fig. 3A). In contrast to peptide
hydrolysis (Table 1), AMPPNP and ATPcS do not eﬃciently
promote casein degradation (Fig. 3A). The non-hydrolysable
ATP analogues stimulate the reaction merely 1.5–2 fold, sug-
gesting that translocation of larger substrates to the proteolytic
sites is energy dependent (Fig. 3A and Table 2). DegradationFig. 3. Degradation of FITC casein. (A) 116 nM TaLon was incubated
with 20 lM of FITC casein in assay buﬀer and ﬂuorescence was
measured over time in the absence or presence of diﬀerent nucleotides
(2 mM of ATP, ADP, ATPcS or AMPPNP). (B) Time course of b-
casein degradation by TaLon. 46.5 nM TaLon was incubated with 50
lM b-casein in the presence of 2 mM ATP for 3 h at 60 C. Every 30
min, a sample was taken from the reaction mixture and analysed by
reversed phase chromatography. The degradation products were de-
tected by absorption at 215 nm.of unfolded protein substrates by EcLon also requires ATP
and is inhibited by ADP. Non-hydrolysable analogues of ATP
allow degradation of casein by EcLon with 20% of the rate
observed with ATP, which perfectly matches with our data set
[7].
Time resolved analysis of b-casein degradation revealed
processive proteolytic activity of TaLon (compare Fig. 3B).
The elution patterns for all time points shown are identical,
only the amount of the individual degradation products in-
creased over the reaction time. This showed that TaLon de-
graded substrates in a processive manner, which is a
characteristic feature of ATP-dependent proteases, e.g., E. coli
ClpP protease, archaeal and mammalian 20S proteasomes,
mammalian 26S proteasomes and E. coli and T. thermophilus
FtsH proteases [26–30].
3.5. The AAAþ mutants
In order to determine the function of conserved AAA+
residues of the TaLon, we generated a set of mutants including
Walker A lysine (K63A), Walker B aspartate (D241A), sensor
1 asparagine (N293A), arginine ﬁnger (R305A), sensor 2 ar-
ginine (R382A) and an additional arginine residue in close
proximity to sensor 2, dubbed sensor 20 (R375A), the latter
being absolutely conserved among archaeal Lon proteases
(Fig. 1). Like TaLonwt all mutant proteins puriﬁed in this
study assembled into high molecular weight complexes, as
shown upon gel ﬁltration (data not shown), indicating that the
mutations did not aﬀect oligomerisation.
The Walker A mutant TaLonK63A lacked ATPase activity
completely. As found for TaLonwt, the peptidase activity re-
mained largely unaﬀected by addition of ATP or its non-hy-
drolysable analogues, but in contrast to TaLonwt the
peptidase activity was not inhibited by ADP (Table 1). The
protease activity of TaLonK63A corresponded to the activity
of TaLonwt in the absence of nucleotide or in the presence of
non-hydrolysable analogues (Table 2). Importantly, this ac-
tivity was not inhibited by ADP nor stimulated by ATP. Since
the Walker A residue is responsible for coordination of the b-
and c-phosphate residues of ATP [20,31], TaLonK63A is most
likely impaired in nucleotide binding, explaining the indiﬀer-
ence of its peptidase and protease activities against the addi-
tion of diﬀerent nucleotides.
The Walker B mutant TaLonD241A retained 5% ATPase
activity. As the Walker B residue is involved in coordination of
the b- and c-phosphates via an Mg2þ ion [32], the greatly re-
duced ATPase activity of TaLonD241A is most likely a con-
sequence of impaired coordination. Remarkably, in the
Table 2
Relative ATPase and protease activities of wt and mutant TaLona
ATPase (%)a FITC casein degradation (%)
No nucl. ADP AMPPNP ATPcS ATP
Wt 100 2 9 1 2 1 15 2 19 1 100 3
Mutant Motif
K63A Walker A 0 12 1 10 1 12 1 12 1 19 1
D241A Walker B 8 1 17 1 9 1 7 1 13 2 17 3
N293A Sensor 1 8 1 10 1 2 1 11 0 20 2 25 2
R305A R-ﬁnger 43 1 0 0 0 6 2 65 6
R375A Sensor 20 2 1 12 1 1 1 8 2 6 1 9 2
R382A Sensor 2 53 3 1 1 0 1 1 6 1 69 4
aATPase activities were measured in the presence of 5 lM FITC casein. ATPase activities and casein degradation are given relative to the respective
activities of the wt TaLon protease.
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from TaLonwt, but the peptidase activity was reduced to
about 60% irrespective of whether ADP, ATP or its analogues
were added (Table 1). This indicates that the binding of nu-
cleotide without c-phosphate (ADP) or with uncoordinated c-
phosphate inhibits the peptidase activity of TaLonD241A. The
degree of inhibition is comparable with the eﬀect of ADP on
TaLonwt. As a consequence of the lack of ATPase acitvity, the
proteolytic acitvity was greatly impaired and could not be
stimulated by addition of nucleotides (Table 2).
Sensor 1 is a conserved polar residue among AAAþ proteins,
which was proposed originally to sense the nucleotide state of
the ATP-binding pocket [33,34]. However, meanwhile it was
shown that mutation of the sensor 1 residue impairs the AT-
Pase activity dramatically, suggesting that sensor 1 has a cat-
alytic role [35,36]. Consistently, the sensor 1 mutant
TaLonN293A displayed very low ATPase activity, but the
regulation of the peptidase activity by binding of diﬀerent
nucleotides remained largely unaﬀected (Table 1). The prote-
olytic activity was severely reduced, irrespective of the absence
or presence of nucleotides (Table 2). Thus, we suggest a cat-
alytic role for the TaLon sensor 1 residue in ATP hydrolysis.
Unexpectedly, mutating the sensor 20 arginine, which is in
close proximity to the sensor 2 residue and absolutely con-
served in archaeal Lon proteases, reduced ATP hydrolysis of
TaLonR375A close to zero (Table 1). Notably, there is also a
conserved arginine residue (R537) in the bacterial Lon prote-
ases close to the sensor 2 residue (R542). In the recently
published structure of the AAAþ a domain of the EcLon
protease, arginine 537 is located at the end of helix 2 followed
by a short loop and sensor 2 arginine 542 at the beginning of
helix 3 [37]. Since sensor 20 points into the same direction as
sensor 2, it might also hydrolyse and/or sense the c-phosphate
of a bound nucleotide, like described for sensor 2 in diﬀerent
proteins [38]. The peptidase activity was similar to TaLonwt
and was inhibited by ADP (Table 1). The protease activity was
severely reduced under all assay conditions (Table 2) resem-
bling the sensor 1 mutant TaLon N293A.
Hexameric AAAþ structures revealed that the arginine ﬁn-
ger protrudes into the catalytic site of a neighbouring subunit
pointing towards the c-phosphate in a way, which would en-
able it to stimulate hydrolysis [33,39,40]. Similarly, sensor 2,
located in the helical C-terminal subdomain of the AAAþ
domain, was shown to be involved in ATP hydrolysis or
sensing of the nucleotide state, however not in a neighbouring
but in its inherent subunit [34,38,41].Mutation of the arginine ﬁnger or sensor 2 arginine to al-
anine resulted in a signiﬁcantly decreased ATPase activity of
the respective mutants TaLonR305A and TaLon382A. More
dramatically, the peptidase activity of both mutants was to-
tally impaired in the absence of nucleotide or in the presence
of ADP (Table 1). Addition of ATP or ATPcS stimulated the
peptidase activity close to wt level, whereas AMPPNP for
reasons not known stimulated only moderately (Table 1). We
conclude that in the absence of a c-phosphate both mutants
adopted a conformation incompetent for peptide hydrolysis,
which was tranformed into an active conformation when
nucleotides containing a c-phosphate were added. The pro-
teolytic activity of both mutant TaLon proteases was extin-
guished completely in the absence of nucleotide, or in the
presence of ADP or AMPPNP. Addition of ATPcS stimu-
lated marginally, but ATP activated proteolysis up to 70% of
wt activity (Table 2). Thus, the arginine ﬁnger and the sensor
2 arginine contribute to ATP binding and/or hydrolysis, but
are essential for coupling of nucleotide hydrolysis to protein
degradation.4. Discussion
In this paper, we present a thorough characterisation of the
archaeal Lon protease from T. acidophilum. TaLon was found
to be membrane bound in Thermoplasma and when overex-
pressed in E. coli. It formed a stable homooligomeric complex
of probably six subunits and no nucleotide was needed for
assembly. TaLon showed ATPase and peptidase activity and
degraded protein substrates processively, a common feature of
ATP-dependent proteases. Peptidase activity of TaLon was
only observed in the presence of an aminopeptidase. Interest-
ingly, the membrane-bound, Zn2þ-dependent AAA-protease
FtsH from E. coli (EcFtsH) degraded the Suc-LLVY-AMC
peptide in a similar way, i.e., release of ﬂuorescence was only
detected in the presence of an aminopeptidase [42]. The in-
ternal cleavage of the Suc-LLVY-AMC peptide and the in-
ability to hydrolyse other peptides imply that TaLon and
Escherichia coli FtsH (EcFtsH) have rather narrow substrate
speciﬁcity and might be unable to cleave the peptide-AMC
bond. TkLon showed very low activity towards the peptides
glutaryl-AAF-4-methoxy-2-naphthylamide (MNA) and Suc-
FLF-MNA, which was inhibited by ATP. Unfortunately,
peptidase activity of TkLon was not tested in the presence of
an aminopeptidase [11].
166 H. Besche et al. / FEBS Letters 574 (2004) 161–166For a more detailed analysis of the regulatory mechanisms
within the TaLon oligomer, several ATPase mutants were
generated and analysed with respect to their speciﬁc activities.
We showed that among the highly conserved AAAþ residues,
lysine in Walker A, aspartate in Walker B, the sensor 1 aspar-
agine and sensor 20 arginine were essential for ATPase activity
with only minor inﬂuence on the peptidase activity. In contrast,
two highly conserved arginine residues, sensor 2 and arginine
ﬁnger, contributed only to a minor extent to the overall ATPase
activity. Instead, mutation of the respective residues to alanine
turns TaLon from a nucleotide independent to a strictly
nucleotide dependent peptidase. Interestingly, the presence of
c-phosphate restored peptidase activity of the sensor 2 and
arginine ﬁnger mutants. The proteolytic acitvity, however, was
only reconstituted in the presence of ATP. Therefore, we con-
clude that the c-phosphate of ATP along with the conserved
sensor 2 and arginine ﬁnger residues provided is essential for
nucleotide-dependent activation of the protease domain. While
sensor 2 was found to be involved in interdomain communi-
cation rather than ATP hydrolysis in Hsp104 [43], such a role is
unprecedented for the arginine ﬁnger [38].
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